Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Desipramine hydrochloride bulk supplier for pharma manufacturers

Desipramine Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg

Reference Brands: Norpramin (USA), Pertofrane(EU/UK)

Category: Antipsychotropic Drugs

Desipramine hydrochloride is a tricyclic antidepressant (TCA) that increases the levels of norepinephrine and serotonin in the brain to improve mood and relieve depressive symptoms. It’s used to treat major depressive disorder and sometimes neuropathic pain or ADHD. It should be taken under medical supervision as it can cause side effects such as dry mouth, dizziness, constipation, and heart rhythm changes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Desipramine Hydrochloride — third party manufacturing & bulk supply

Desipramine Hydrochloride is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Desipramine Hydrochloride is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Desipramine Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Desipramine Hydrochloride →
Back to Listing

Frequently Asked Questions

Desipramine hydrochloride is listed as Tablets in 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Desipramine hydrochloride is referenced against Norpramin (USA), Pertofrane(EU/UK). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Clorazepate Dipotassium

Strength:
3.75 mg, 7.5 mg, 15 mg, 5 mg, 10 mg, 20 mg

Form: Tablets, Capsules

Reference Brands: Tranxene (USA), Tranxilium(EU)

View Details
Lumateperone

Strength:
10.5 mg, 21 mg, 42 mg

Form: Capsules

Reference Brands: Caplyta (USA)

View Details
Amoxapine

Strength:
25 mg, 50 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olanzapine + Samidorphan

Strength:
5 mg/10 mg, 10 mg/10 mg, 15 mg/10 mg, 20 mg/10 mg

Form: Tablets

Reference Brands: Lybalvi (USA/EU)

View Details
Citalopram Oral Tablets

Strength:
10 mg, 20 mg, 40 mg

Form: Oral Tablets

Reference Brands: US: Celexa®, Citapram®, Apo-Citalopram®; EU: Cipramil®, Citalon®, Citalec®

View Details
Paroxetine Oral Tablets (Immediate-Release)

Strength:
10 mg, 20 mg, 30 mg, 40 mg

Form: Oral Tablets (immediate-release)

Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®

View Details
Paroxetine Tablet (Extended-Release)

Strength:
12.5 mg, 25 mg, 37.5 mg

Form: Tablet (Extended-Release)

Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®

View Details
Fluvoxamine Tablets

Strength:
25 mg, 50 mg, 100 mg

Form: Tablets

Reference Brands: Luvox(US); Fevarin(EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.